Azenta reported Q2 2025 revenue of $143 million, representing 5% year-over-year growth on a reported basis and 6% on an organic basis. The company achieved a non-GAAP EPS of $0.05 and an adjusted ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

However, Azenta reported a 2% dip in organic revenue for the fourth quarter, amounting to $170 million. Despite a decrease in annual revenue for FY 2024, totaling $656 million, Azenta's core ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Azenta (NASDAQ:AZTA) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Azenta will report ...

Azenta Life Sciences, a key player in the life sciences industry, is poised for financial recovery with a robust Q2 performance and cost-cutting measures, making it an enticing investment opportunity.

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday before the bell. Here’s what to look for. Azenta beat analysts’ revenue expectations by 2% last quarter, reporting ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q4 CY2025 results , but sales were flat year on year at $148.6 million. Its non-GAAP profit of $0.14 per share was in line with analysts’ consensus ...